Popular
- Oncology and Hematology
SunRISe-1: TAR-200 in BCG-Unresponsive High-Risk Bladder Cancer
- Oncology and Hematology
Evolving Trends in Germline Genetic Testing for Prostate Cancer
- Oncology and Hematology
Updates from Apa-RP: Apalutamide and ADT in High-Risk Localized Prostate Cancer
John Berk, MD
Sami Khella, MD
John Berk, MD
Noel Dasgupta, MD, FACC
Sami Khella, MD
Marcia Waddington-Cruz, MD, PhD
Sami Khella, MD
Marcia Waddington-Cruz, MD, PhD
John Berk, MD
Sami Khella, MD
Sami Khella, MD
Omer Abdul Hamid, MD
Nancy Kuntz, MD
Migvis Monduy, MD
- MinuteCE®
ADCs on the Horizon for Breast Cancer: Managing Treatment-Emergent Toxicities
1.00 program creditNadia Harbeck, MD, PhD
Nadia Harbeck, MD, PhD
Egbert Smit, MD
Egbert Smit, MD